{"entity":{"type":"insider","cik":"0001495856","url":"/insider/0001495856","json_url":"/insider/0001495856.json","name":"Linn Michael G","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":157,"n_filings":18,"first":"2011-05-05","last":"2025-08-21","span_basis":"filed_date"},"name_variants":[{"name":"Linn Michael G","source":"filing","n_filings":18,"first_seen":"2011-05-05","last_seen":"2025-08-21"}],"transactions":[{"id":4870771,"accession":"0000908834-25-000268","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000908834-25-000268","line_url":"/filing/0000908834-25-000268#line-2","is_derivative":false,"issuer_cik":"0001040153","issuer_name":"Lantheus Holdings, Inc.","issuer_ticker":"LNTH","issuer_name_source":null,"issuer_url":"/issuer/0001040153","owner_cik":null,"owner_name":"Dapice Joshua J.; Dreyfuss Philip D; Dunn Hannah E.; FARALLON PARTNERS L L C/CA; FRIED RICHARD B; Gehani Varun N; Giauque Nicolas; Kim David T; Linn Michael G; Luo Patrick (Cheng)","owner_display_name":"Dapice Joshua J.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3365000.0,"shares_display":"3,365,000","price_per_share":56.15,"price_display":"56.15","price_state":"stated","total_value":188944750.0,"total_display":"188,944,750.00","total_whole":"188,944,750","shares_owned_after":3477227.0,"shares_owned_after_display":"3,477,227","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-20","filed_date":"2025-08-21","scope":"insider"},{"id":4870764,"accession":"0000908834-25-000268","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000908834-25-000268","line_url":"/filing/0000908834-25-000268#line-1","is_derivative":false,"issuer_cik":"0001040153","issuer_name":"Lantheus Holdings, Inc.","issuer_ticker":"LNTH","issuer_name_source":null,"issuer_url":"/issuer/0001040153","owner_cik":null,"owner_name":"Dapice Joshua J.; Dreyfuss Philip D; Dunn Hannah E.; FARALLON PARTNERS L L C/CA; FRIED RICHARD B; Gehani Varun N; Giauque Nicolas; Kim David T; Linn Michael G; Luo Patrick (Cheng)","owner_display_name":"Dapice Joshua J.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41000.0,"shares_display":"41,000","price_per_share":55.34,"price_display":"55.34","price_state":"stated","total_value":2268940.0,"total_display":"2,268,940.00","total_whole":"2,268,940","shares_owned_after":6842227.0,"shares_owned_after_display":"6,842,227","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-19","filed_date":"2025-08-21","scope":"insider"},{"id":5209174,"accession":"0001209191-21-064382","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-064382","line_url":"/filing/0001209191-21-064382","is_derivative":false,"issuer_cik":"0001040153","issuer_name":"Playa Hotels & Resorts N.V.","issuer_ticker":"PLYA","issuer_name_source":null,"issuer_url":"/issuer/0001040153","owner_cik":null,"owner_name":"FARALLON PARTNERS L L C/CA; FRIED RICHARD B; Linn Michael G; PATEL RAJIV A; Dreyfuss Philip D; Kim David T; Roberts Thomas G. Jr.; Fisch Michael B.","owner_display_name":"FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares, par value Euro 0.10 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8352553.0,"shares_display":"8,352,553","price_per_share":8.12,"price_display":"8.12","price_state":"stated","total_value":67822730.36,"total_display":"67,822,730.36","total_whole":"67,822,730","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-12","filed_date":"2021-11-15","scope":"insider","n_lines":2},{"id":5333522,"accession":"0001209191-21-034820","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-034820","line_url":"/filing/0001209191-21-034820","is_derivative":false,"issuer_cik":"0001040153","issuer_name":"Playa Hotels & Resorts N.V.","issuer_ticker":"PLYA","issuer_name_source":null,"issuer_url":"/issuer/0001040153","owner_cik":null,"owner_name":"FARALLON PARTNERS L L C/CA; FRIED RICHARD B; Linn Michael G; Fisch Michael B.; Kim David T; Roberts Thomas G. Jr.; PATEL RAJIV A; Dreyfuss Philip D","owner_display_name":"FARALLON PARTNERS L L C/CA","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares, par value Euro 0.10 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6642314.0,"shares_display":"6,642,314","price_per_share":6.88,"price_display":"6.88","price_state":"stated","total_value":45699120.32,"total_display":"45,699,120.32","total_whole":"45,699,120","shares_owned_after":7937523.0,"shares_owned_after_display":"7,937,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-19","filed_date":"2021-05-21","scope":"insider","n_lines":2},{"id":3132976,"accession":"0001214659-20-005727","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-20-005727","line_url":"/filing/0001214659-20-005727#line-2","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Generation Bio Co.","issuer_ticker":"GBIO","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Dreyfuss Philip D; FARALLON CAPITAL MANAGEMENT LLC; FARALLON PARTNERS L L C/CA; FRIED RICHARD B; Fisch Michael B.; Kim David T; Linn Michael G; PATEL RAJIV A; Roberts Thomas G. Jr.; Zone Healthcare Holdings, LLC","owner_display_name":"Dreyfuss Philip D","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":7600000.0,"total_display":"7,600,000.00","total_whole":"7,600,000","shares_owned_after":1918819.0,"shares_owned_after_display":"1,918,819","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-16","filed_date":"2020-06-17","scope":"insider"},{"id":4538143,"accession":"0001182489-17-000370","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001182489-17-000370","line_url":"/filing/0001182489-17-000370","is_derivative":false,"issuer_cik":"0001245635","issuer_name":"TOWN SPORTS INTERNATIONAL HOLDINGS INC","issuer_ticker":"CLUB","issuer_name_source":null,"issuer_url":"/issuer/0001245635","owner_cik":null,"owner_name":"Warren John R.; Linn Michael G; Paidipaty Ravi K; PATEL RAJIV A; Roberts Thomas G. Jr.; Spokes Andrew J M; WEHRLY MARK C; Seybold William","owner_display_name":"Warren John R.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":210082.0,"shares_display":"210,082","price_per_share":3.6,"price_display":"3.60","price_state":"stated","total_value":756295.2,"total_display":"756,295.20","total_whole":"756,295","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-19","filed_date":"2017-06-20","scope":"insider","n_lines":5},{"id":4538131,"accession":"0001182489-17-000370","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001182489-17-000370","line_url":"/filing/0001182489-17-000370","is_derivative":false,"issuer_cik":"0001245635","issuer_name":"TOWN SPORTS INTERNATIONAL HOLDINGS INC","issuer_ticker":"CLUB","issuer_name_source":null,"issuer_url":"/issuer/0001245635","owner_cik":null,"owner_name":"Warren John R.; Linn Michael G; Paidipaty Ravi K; PATEL RAJIV A; Roberts Thomas G. Jr.; Spokes Andrew J M; WEHRLY MARK C; Seybold William","owner_display_name":"Warren John R.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3850000.0,"shares_display":"3,850,000","price_per_share":3.6,"price_display":"3.60","price_state":"stated","total_value":13860000.0,"total_display":"13,860,000.00","total_whole":"13,860,000","shares_owned_after":81462.0,"shares_owned_after_display":"81,462","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-16","filed_date":"2017-06-20","scope":"insider","n_lines":5},{"id":2727771,"accession":"0001182489-16-000974","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_display_name":"Hirsch Daniel J.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28662.0,"shares_display":"28,662","price_per_share":3.36,"price_display":"3.36","price_state":"stated","total_value":96304.32,"total_display":"96,304.32","total_whole":"96,304","shares_owned_after":2648696.0,"shares_owned_after_display":"2,648,696","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-26","filed_date":"2016-02-26","scope":"insider","n_lines":8},{"id":2727729,"accession":"0001182489-16-000974","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_display_name":"Hirsch Daniel J.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":197082.0,"shares_display":"197,082","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":626720.76,"total_display":"626,720.76","total_whole":"626,721","shares_owned_after":2639142.0,"shares_owned_after_display":"2,639,142","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-25","filed_date":"2016-02-26","scope":"insider","n_lines":8},{"id":2727668,"accession":"0001182489-16-000974","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001182489-16-000974","line_url":"/filing/0001182489-16-000974","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; Kim David T; FARALLON CAPITAL MANAGEMENT LLC; Spokes Andrew J M; Fisch Michael B.; LANDRY MONICA R; Roberts Thomas G. Jr.; FARALLON PARTNERS L L C/CA","owner_display_name":"Hirsch Daniel J.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":209256.0,"shares_display":"209,256","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":665434.08,"total_display":"665,434.08","total_whole":"665,434","shares_owned_after":2573448.0,"shares_owned_after_display":"2,573,448","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-24","filed_date":"2016-02-26","scope":"insider","n_lines":8},{"id":8773006,"accession":"0001182489-15-000697","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001182489-15-000697","line_url":"/filing/0001182489-15-000697","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Spokes Andrew J M; Roberts Thomas G. Jr.; FARALLON CAPITAL MANAGEMENT LLC; Fisch Michael B.; Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; LANDRY MONICA R; Kim David T; FARALLON PARTNERS L L C/CA","owner_display_name":"Spokes Andrew J M","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10800.0,"shares_display":"10,800","price_per_share":6.48,"price_display":"6.48","price_state":"stated","total_value":69984.0,"total_display":"69,984.00","total_whole":"69,984","shares_owned_after":2503696.0,"shares_owned_after_display":"2,503,696","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-09-10","filed_date":"2015-09-11","scope":"insider","n_lines":8},{"id":8772998,"accession":"0001182489-15-000697","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001182489-15-000697","line_url":"/filing/0001182489-15-000697#line-8","is_derivative":false,"issuer_cik":"0000909661","issuer_name":"Nexvet Biopharma plc","issuer_ticker":"NVET","issuer_name_source":null,"issuer_url":"/issuer/0000909661","owner_cik":null,"owner_name":"Spokes Andrew J M; Roberts Thomas G. Jr.; FARALLON CAPITAL MANAGEMENT LLC; Fisch Michael B.; Hirsch Daniel J.; FRIED RICHARD B; Linn Michael G; LANDRY MONICA R; Kim David T; FARALLON PARTNERS L L C/CA","owner_display_name":"Spokes Andrew J M","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":5.75,"price_display":"5.75","price_state":"stated","total_value":575.0,"total_display":"575.00","total_whole":"575","shares_owned_after":2500096.0,"shares_owned_after_display":"2,500,096","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-09-09","filed_date":"2015-09-11","scope":"insider"}],"collapsed":true,"next_cursor":"2015-09-09|8772998","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001521036","name":"Lantheus Holdings, Inc.","url":"/issuer/0001521036","role":"Other","n_filings":1,"first_seen":"2025-08-21","last_seen":"2025-08-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001692412","name":"Playa Hotels & Resorts N.V.","url":"/issuer/0001692412","role":"Other","n_filings":2,"first_seen":"2021-05-21","last_seen":"2021-11-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001733294","name":"Generation Bio Co.","url":"/issuer/0001733294","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2020-06-17","last_seen":"2020-06-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001281774","name":"TOWN SPORTS INTERNATIONAL HOLDINGS INC","url":"/issuer/0001281774","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2017-06-20","last_seen":"2017-06-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001618561","name":"Nexvet Biopharma plc","url":"/issuer/0001618561","role":"Ten percent owner, Other","n_filings":2,"first_seen":"2015-09-11","last_seen":"2016-02-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001482512","name":"Hudson Pacific Properties, Inc.","url":"/issuer/0001482512","role":"Ten percent owner, Other","n_filings":4,"first_seen":"2011-05-05","last_seen":"2015-04-13"},{"type":"issuer","type_label":"ISSUER","cik":"0000859475","name":"TRIDENT MICROSYSTEMS INC","url":"/issuer/0000859475","role":"Ten percent owner, Other","n_filings":7,"first_seen":"2012-11-28","last_seen":"2012-12-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001495856","retrieved_at":"2026-08-24T17:32:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}